@article{briganti2018active,
  title={Active surveillance for low-risk prostate cancer: the {European Association of Urology} position in 2018},
  author={Briganti, Alberto and Fossati, Nicola and Catto, James WF and Cornford, Philip and Montorsi, Francesco and Mottet, Nicolas and Wirth, Manfred and Van Poppel, Hendrik},
  journal={European urology},
  volume={74},
  number={3},
  pages={357--368},
  year={2018},
  publisher={Elsevier}
}

@article{coley2017prediction,
  title={Prediction of the pathologic Gleason score to inform a personalized management program for prostate cancer},
  author={Coley, R Yates and Zeger, Scott L and Mamawala, Mufaddal and Pienta, Kenneth J and Carter, H Ballentine},
  journal={European urology},
  volume={72},
  number={1},
  pages={135--141},
  year={2017},
  publisher={Elsevier}
}

@article{gap3_2018,
  title={The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date},
  author={Bruinsma, Sophie M and Zhang, Liying and Roobol, Monique J and Bangma, Chris H and Steyerberg, Ewout W and Nieboer, Daan and Van Hemelrijck, Mieke and Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium and Trock, Bruce and Ehdaie, Behfar and others},
  journal={BJU international},
  volume={121},
  number={5},
  pages={737--744},
  year={2018},
  publisher={Wiley Online Library}
}

@book{rizopoulos2012joint,
title={Joint Models for Longitudinal and Time-to-Event Data: With Applications in R},
author={Rizopoulos, Dimitris},
year={2012},
publisher={CRC Press},
isbn = {9781439872864}
}

@article{ito2003natural,
  title={Natural history of PSA increase with and without prostate cancer},
  author={Ito, Kazuto and Yamamoto, Takumi and Ohi, Masaru and Takechi, Hiroyuki and Kurokawa, Kohei and Suzuki, Kazuhiro and Yamanaka, Hidetoshi},
  journal={Urology},
  volume={62},
  number={1},
  pages={64--69},
  year={2003},
  publisher={Elsevier}
}

@article{loeb2014heterogeneity,
  title={Heterogeneity in active surveillance protocols worldwide},
  author={Loeb, Stacy and Carter, H Ballentine and Schwartz, Mark and Fagerlin, Angela and Braithwaite, R Scott and Lepor, Herbert},
  journal={Reviews in urology},
  volume={16},
  number={4},
  pages={202--203},
  year={2014},
  publisher={MedReviews, LLC}
}

@article{bratt2013study,
  title={The Study of Active Monitoring in Sweden (SAMS): a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer},
  author={Bratt, Ola and Carlsson, Stefan and Holmberg, Erik and Holmberg, Lars and Johansson, Eva and Josefsson, Andreas and Nilsson, Annika and Nyberg, Maria and Robinsson, David and Sandberg, Jonas and others},
  journal={Scandinavian journal of urology},
  volume={47},
  number={5},
  pages={347--355},
  year={2013},
  publisher={Taylor \& Francis}
}

@article{bul2013active,
  title={Active surveillance for low-risk prostate cancer worldwide: the PRIAS study},
  author={Bul, Meelan and Zhu, Xiaoye and Valdagni, Riccardo and Pickles, Tom and Kakehi, Yoshiyuki and Rannikko, Antti and Bjartell, Anders and Van Der Schoot, Deric K and Cornel, Erik B and Conti, Giario N and others},
  journal={European urology},
  volume={63},
  number={4},
  pages={597--603},
  year={2013},
  publisher={Elsevier}
}

@article{nieboer2018active,
  title={Active surveillance: a review of risk-based, dynamic monitoring},
  author={Nieboer, Daan and Tomer, Anirudh and Rizopoulos, Dimitris and Roobol, Monique J and Steyerberg, Ewout W},
  journal={Translational andrology and urology},
  volume={7},
  number={1},
  pages={106--115},
  year={2018},
  publisher={AME Publications}
}

@article{inoue2018comparative,
  title={Comparative analysis of biopsy upgrading in four prostate cancer active surveillance cohorts},
  author={Inoue, Lurdes YT and Lin, Daniel W and Newcomb, Lisa F and Leonardson, Amy S and Ankerst, Donna and Gulati, Roman and Carter, H Ballentine and Trock, Bruce J and Carroll, Peter R and Cooperberg, Matthew R and others},
  journal={Annals of internal medicine},
  volume={168},
  number={1},
  pages={1--9},
  year={2018},
  publisher={Am Coll Physicians}
}

@article{bokhorst2015compliance,
title={Compliance rates with the {Prostate Cancer Research International Active Surveillance (PRIAS)} protocol and disease reclassification in noncompliers},
author={Bokhorst, Leonard P and Alberts, Arnout R and Rannikko, Antti and Valdagni, Riccardo and Pickles, Tom and Kakehi, Yoshiyuki and Bangma, Chris H and Roobol, Monique J and {\relax PRIAS study group}},
journal={European Urology},
volume={68},
number={5},
pages={814--821},
year={2015},
publisher={Elsevier}
}

@article{carvalho2017,
  title={When should active surveillance for prostate cancer stop if no progression is detected?},
  author={de Carvalho, Tiago M and Heijnsdijk, Eveline AM and de Koning, Harry J},
  journal={The Prostate},
  volume={77},
  number={9},
  pages={962--969},
  year={2017},
  publisher={Wiley Online Library}
}

@article{tomer2019,
author = {Tomer, Anirudh and Nieboer, Daan and Roobol, Monique J. and Steyerberg, Ewout W. and Rizopoulos, Dimitris},
title = {Personalized schedules for surveillance of low-risk prostate cancer patients},
journal = {Biometrics},
volume = {75},
number = {1},
pages = {153-162},
keywords = {Active surveillance, Biopsy, Joint models, Personalized medicine, Prostate cancer},
doi = {10.1111/biom.12940},
year = {2019}
}